Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Inter-species differences in drug properties.

J M Collins1

  • 1Laboratory of Clinical Pharmacology, Food and Drug Administration, 4 Research Court, Room 314, Rockville, MD 20850, USA. collinsj@cder.fda.gov

Chemico-Biological Interactions
|May 5, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<i>Mycobacterium tuberculosis</i> genotypes isolated from clinical specimens of extrapulmonary TB.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2025
Same author

Behavioral, metabolic, and lipidomic characterization of the 5xFADxTg30 mouse model of Alzheimer's disease.

iScience·2024
Same author

The impact of the COVID-19 pandemic on UK medical education. A nationwide student survey.

Medical teacher·2021
Same author

Clinical outcomes among patients with tuberculous meningitis receiving intensified treatment regimens.

The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease·2021
Same author

Highly Variable Expression of <i>ESR1</i> Splice Variants in Human Liver: Implication in the Liver Gene Expression Regulation and Inter-Person Variability in Drug Metabolism and Liver Related Diseases.

Journal of molecular and genetic medicine : an international journal of biomedical research·2020
Same author

The blueprint for prevention of nosocomial tuberculosis transmission is clear, but why don't we have the will to follow it?

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2020
Same journal

AMPK Activation by AICAR Mitigates Hypoxic Corneal Damage Through Rebuilding Energy and Metabolic Homeostasis.

Chemico-biological interactions·2026
Same journal

Interactions-Guided Blueprint of Acetylcholinesterase Binding: A Review on Structural and Molecular Determinants.

Chemico-biological interactions·2026
Same journal

Diazepam induces mitotic defects and cytotoxicity through modulation of tubulin and Eg5.

Chemico-biological interactions·2026
Same journal

Epigallocatechin-3-gallate, L-theanine and theophylline abolish high-glucose-induced renal cell senescence and subsequent epithelial-mesenchymal transition and fibroblast activation via SIRT1/PGC-1α axis: Implications for diabetic kidney disease.

Chemico-biological interactions·2026
Same journal

TCEP Induces Liver Injury Through Suppression of the PI3K/AKT Axis: Integrated Evidence from Epidemiology, Network Toxicology, and In Vivo Validation.

Chemico-biological interactions·2026
Same journal

Toxicity assessment of three emerging bisphenols (BPA, BPAP and BPC) and their binary mixtures in an advanced in vitro 3D HepG2 cell model.

Chemico-biological interactions·2026
See all related articles

Understanding interspecies differences is crucial for effective drug development. Comparative animal and human data enhance experimental design and risk assessment for new therapeutics.

Area of Science:

  • Pharmacology
  • Toxicology
  • Drug Development

Background:

  • Decreasing reliance on animal studies, increasing use of human-derived tissues.
  • Need for interspecies difference investigations in drug development.
  • Importance of comparative data for experimental design and risk assessment.

Purpose of the Study:

  • Illustrate the necessity of interspecies difference studies using FDA laboratory examples.
  • Demonstrate how comparative data improves drug development.
  • Highlight the application of interspecies data for prospective and retrospective analysis.

Main Methods:

  • Analysis of drug metabolism and pharmacokinetics across species (paclitaxel, zidovudine).
  • Evaluation of parent drug versus metabolite toxicity and efficacy (iododeoxydoxorubicin).

Related Experiment Videos

  • Investigation of enzyme activity differences (arylamine N-acetyltransferases) and implications for drug exposure.

    • Main Results:

    • Rat metabolism studies for paclitaxel were irrelevant to human drug-drug interactions.
    • Zidovudine (AZT) half-life in humans was shorter than predicted from animal studies due to rapid glucuronidation.
    • Significant differences in parent drug vs. metabolite exposure (iododeoxydoxorubicin) and enzyme activity (NAT) necessitate careful interspecies comparison.

    Conclusions:

    • Despite decreasing animal use, effective use of animal data for drug development has increased.
    • Comparative interspecies data are vital for prospective animal experiment design.
    • Interspecies data are essential for interpreting animal findings regarding human risk and benefit.